Home>Topics>Stocks>Arena Pharmaceuticals

Arena Pharmaceuticals ARNA

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. Cramer's Lightning Round - I Was Too Bullish On LinkedIn (4/15/14)

      Headlines

      Wed, 16 Apr 2014

      By SA Editor Miriam Metzinger : Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday April 15. Bullish Calls: Constellation Brands ( STZ ): "Buy it. STZ is too far off its high. I'm not distressed by its chart." Teva Pharmaceuticals ( TEVA ): "Sell half...I'm

    2. What Arena's Belviq Television Ad Campaign Means For The Stock

      Headlines

      Mon, 14 Apr 2014

      By Spencer Osborne : The weight loss drug Belviq from Arena Pharmaceuticals ( ARNA ) is now being promoted on television with a national advertising campaign . This is a day that many long term investors have been

    3. Arena - Belviq Sales Up Modestly Heading Into Television Ads

      Headlines

      Fri, 11 Apr 2014

      By Spencer Osborne : It is certainly an interesting time to be an investor in Arena Pharmaceuticals ( ARNA ). The company is about 10 months into its launch of the anti-obesity drug Belviq and the equity has taken several lumps along

    4. Why The Federal Employees Health Benefits Letter Is A Big Deal For Belviq

      Headlines

      Wed, 9 Apr 2014

      in moving Eisai to the goal of 70% insurance coverage for Belviq in 2014, and getting there ahead of schedule. To understand why the FEHB letter is a very big deal for Arena ( ARNA ) and Eisai and Belviq sales, we need to Complete Story »

    5. Arena Script Sales Close Out Quarter On Positive Note

      Headlines

      Fri, 4 Apr 2014

      By Spencer Osborne : Sales of the Arena Pharmaceuticals ( ARNA ) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing

    6. Arena - Scripts, Ads, Sales Reps

      Headlines

      Fri, 28 Mar 2014

      By Spencer Osborne : While the Arena ( ARNA ) equity may not have been too exciting of late, there are some interesting developments about to begin. The key here is understanding

    7. Direct-To-Consumer Television Advertising Marks The Tipping Point For Belviq Sales

      Headlines

      Mon, 24 Mar 2014

      Dedvukaj: BELVIQ's launch started on June 11, 2013 and so far, sales have been slowly creeping up for investors. Arena ( ARNA ) and its marketing partner Eisai ( OTCPK:ESALY ) recently announced a major new stage in commercialization strategy and promotional

    8. Arena Down With Overall Market - Sales Data No Help

      Headlines

      Mon, 17 Mar 2014

      By Spencer Osborne : As we head toward the end of the first quarter, and the fiscal year end for Arena's ( ARNA ) marketing partner Eisai ( OTCPK:ESALY ), it is appropriate to assess where we are for both companies in terms of the sales

    9. Arena Sees Growth Continue With Belviq

      Headlines

      Fri, 7 Mar 2014

      By Spencer Osborne : The script numbers for Arena Pharmaceuticals ( ARNA ) Belviq for the last week in February are in. According to industry tracker IMS, the prescriptions for Belviq came in just under

    10. Have Anti-Obesity Drug Companies Failed?

      Headlines

      Fri, 7 Mar 2014

      patients alike would flock to the only two FDA approved weight control therapies offered by VIVUS ( VVUS ) and Arena Pharmaceuticals ( ARNA ) to aide in weight loss over and above diet and exercise. After all, obesity has assumed the dimensions

    « Prev12345Next »
    Content Partners